The successful treatment of a multidrug-resistant Achromobacter xylosoxidans corneal ulcer with topical meropenem

BMJ Case Rep. 2018 Jul 18:2018:bcr2018225163. doi: 10.1136/bcr-2018-225163.

Abstract

Microbial keratitis is a common corneal condition, with many known risk factors. We present a case of an 88-year-old female patient with a multidrug-resistant Achromobacter xylosoxidans corneal ulcer in a previously failed second penetrating keratoplasty, successfully managed with topical meropenem drops administered hourly around the clock, for five days preceding and then hourly day only, for five days following a repeat third penetrating keratoplasty. Topical meropenem 50 mg/mL was prepared by mixing a 500 mg vial of meropenem with 10 mL of sterile water with pharmacy advice that administration should be within an hour. To the best of our knowledge, this is the first report of the use of topical meropenem in the management of A.xylosoxidans keratitis. This case highlights the importance of the mean inhibitory concentrations for antibiotics when considering sensitivities. Topical meropenem may be a useful treatment option for multidrug-resistant bacterial corneal ulcers that are resistant to conventional therapy.

Keywords: eye; ophthalmology.

Publication types

  • Case Reports

MeSH terms

  • Achromobacter denitrificans* / drug effects
  • Administration, Ophthalmic
  • Aged, 80 and over
  • Anti-Bacterial Agents / administration & dosage*
  • Corneal Ulcer / drug therapy*
  • Corneal Ulcer / microbiology
  • Corneal Ulcer / surgery
  • Drug Resistance, Multiple
  • Drug Resistance, Multiple, Bacterial
  • Eye Infections, Bacterial / drug therapy*
  • Eye Infections, Bacterial / microbiology
  • Female
  • Gram-Negative Bacterial Infections / drug therapy*
  • Gram-Negative Bacterial Infections / microbiology
  • Humans
  • Keratoplasty, Penetrating
  • Meropenem
  • Preoperative Care / methods
  • Thienamycins / administration & dosage*

Substances

  • Anti-Bacterial Agents
  • Thienamycins
  • Meropenem